Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-02 4:30 pm Purchase |
2022-04-21 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
ADAGE CAPITAL PARTNERS GP LLC | 93,333 8.080% |
93,333 (New Position) |
Filing History |
| 2022-03-08 08:58 am Purchase |
2022-03-01 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Moshe Arkin | 60,874 5.380% |
60,874 (New Position) |
Filing History |
| 2022-02-11 6:34 pm Purchase |
2021-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
683 Capital Management, LLC | 110,000 9.700% |
20,547 (+22.97%) |
Filing History |
| 2022-02-11 5:23 pm Sale |
2021-12-31 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Vivo Ventures VI LLC | 139 13.000% |
-55,431 (-99.75%) |
Filing History |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
BLACKROCK INC BLK |
82,432 7.300% |
3,256 (+4.11%) |
Filing History |
| 2022-01-21 3:25 pm Purchase |
2021-12-27 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
234,961 20.750% |
39,639 (+20.29%) |
Filing History |
| 2021-09-10 10:31 am Purchase |
2021-08-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
195,322 17.260% |
64,594 (+49.41%) |
Filing History |
| 2021-08-06 4:30 pm Sale |
2021-08-05 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Vivo Ventures VI LLC | 55,570 4.910% |
-4,000 (-6.71%) |
Filing History |
| 2021-02-16 3:18 pm Purchase |
2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
683 Capital Management, LLC | 89,453 8.200% |
89,453 (New Position) |
Filing History |
| 2021-02-12 4:30 pm Unchanged |
2020-12-31 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Vivo Ventures VI LLC | 59,570 5.500% |
0 (Unchanged) |
Filing History |
| 2021-02-11 08:25 am Sale |
2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
-74,167 (Position Closed) |
Filing History |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
BLACKROCK INC BLK |
79,176 7.300% |
16,186 (+25.70%) |
Filing History |
| 2021-01-11 11:46 am Purchase |
2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
130,728 12.060% |
130,728 (New Position) |
Filing History |
| 2021-01-04 11:29 am Sale |
2021-01-04 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Broadfin Capital LLC | 0 0.000% |
-41,212 (Position Closed) |
Filing History |